Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients

被引:14
作者
Grima, Pierfrancesco [1 ,2 ]
Fabbiani, Massimiliano [2 ]
Ciccarelli, Nicoletta [2 ,3 ,4 ]
Tana, Mariangela [1 ]
Farina, Salvatore [2 ]
Colafigli, Manuela [2 ]
Mondi, Annalisa [2 ]
Cauda, Roberto [2 ]
Di Giambenedetto, Simona [2 ]
机构
[1] S Caterina Novella Hosp, Div Infect Dis, I-73013 Galatina, Italy
[2] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Memory Clin, I-00168 Rome, Italy
[4] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy
关键词
HIV-associated neurocognitive disorders; Dementia; Cerebrovascular disease; Ophthalmic artery resistance index; VASCULAR RISK-FACTORS; NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; NORMATIVE DATA; PREVALENCE; DISORDERS; DISEASE; PERFORMANCE; DEMENTIA; IMPACT;
D O I
10.1016/j.jinf.2012.07.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Despite the introduction of combined antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HANDs) remains high. Aim of the study was to investigate the potential relationship between ophthalmic artery resistance index (OARI), a marker of subclinical cerebrovascular disease, and cognitive performance. Methods: We performed a cross-sectional cohort study by consecutively enrolling HIV-infected patients during routine outpatient visits. All subjects underwent a comprehensive neuropsycological battery and ultrasonographic assessment of OARI. Patients were classified as cognitively impaired if they showed decreased cognitive function involving at least two ability domains. OARI was considered abnormal if above 0.72 at left or right side. Factors associated with cognitive performance were evaluated by linear and logistic regression analysis. Results: A total of 116 patients [78.4% males, median age 44 years (IQR 37-49), 13.8% with past AIDS-defining events, median CD4 482 cells/mu L (IQR 352-690), 79.3% with HIV RNA <20 copies/mL] were enrolled. A hundred-thirteen (97.4%) subjects were on cART of which 88.5% on current regimen from one year. Fifty-four (46.6%) patients were classified as cognitively impaired. ROC curves indicated that the most discriminant left and right OARI values for predicting a mild cognitive impairment were >0.72 (AUC = 0.73, sensitivity 61.8%, specificity 81.4%, p < 0.001) and >0.71 (AUC = 0.72, sensitivity 69.1%, specificity 71.2%, p < 0.001), respectively. Multivariate analysis showed that OARI >0.72 (OR 4.7, p = 0.001) was independently associated with increased risk of cognitive impairment. Moreover, education (beta = -0.18, p = 0.005), Zung depression score (beta = +0.05, p = 0.021) and an abnormal OARI (beta = +1.46, p = 0.002) were independently associated with an increased number of pathological performances. Evaluating separately each cognitive domain, an abnormal OARI confirmed an independent association with lower performance in attention and executive functions (p = 0.003) and in psychomotor speed (p = 0.010). Conclusions: Increased OARI was associated with lower cognitive performance in HIV-infected patients. These findings suggest a potential role of subclinical cerebrovascular disease in the pathogenesis of HAND. (C) 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 50 条
  • [1] Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure
    Fabbiani, Massimiliano
    Grima, Pierfrancesco
    Borghetti, Alberto
    Colafigli, Manuela
    D'Avino, Alessandro
    Mondi, Annalisa
    Gagliardini, Roberta
    De Luca, Andrea
    Cauda, Roberto
    Di Giambenedetto, Simona
    JOURNAL OF INFECTION, 2014, 68 (05) : 500 - 503
  • [2] Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet, Fabrice
    Amieva, Helene
    Marquant, Fabienne
    Bernard, Charlotte
    Bruyand, Mathias
    Dauchy, Frederic-Antoine
    Mercie, Patrick
    Greib, Carine
    Richert, Laura
    Neau, Didier
    Catheline, Gwenaelle
    Dehail, Patrick
    Dabis, Francois
    Morlat, Philippe
    Dartigues, Jean-Francois
    Chene, Genevieve
    AIDS, 2013, 27 (03) : 391 - 400
  • [3] Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects
    Vergori, Alessandra
    Pinnetti, Carmela
    Lorenzini, Patrizia
    Brita, AnnaClelia
    Libertone, Raffaella
    Mastrorosa, Ilaria
    Cicalini, Stefania
    Antinori, Andrea
    Ammassari, Adriana
    INFECTION, 2019, 47 (06) : 929 - 935
  • [4] Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients
    Fabbiani, M.
    Ciccarelli, N.
    Tana, M.
    Farina, S.
    Baldonero, E.
    Di Cristo, V.
    Colafigli, M.
    Tamburrini, E.
    Cauda, R.
    Silveri, M. C.
    Grima, P.
    Di Giambenedetto, S.
    HIV MEDICINE, 2013, 14 (03) : 136 - 144
  • [5] Cognitive reserve and neuropsychological functioning in older HIV-infected people
    Milanini, Benedetta
    Ciccarelli, Nicoletta
    Fabbiani, Massimiliano
    Limiti, Silio
    Grima, Pierfrancesco
    Rossetti, Barbara
    Visconti, Elena
    Tamburrini, Enrica
    Cauda, Roberto
    Di Giambenedetto, Simona
    JOURNAL OF NEUROVIROLOGY, 2016, 22 (05) : 575 - 583
  • [6] Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment
    Arenas-Pinto, Alejandro
    Winston, Alan
    Stoehr, Wolfgang
    Day, John
    Wiggins, Rebecca
    Quah, Say Pheng
    Ainsworth, Jonathan
    Fleck, Sue
    Dunn, David
    Accoroni, Alex
    Paton, Nicholas I.
    PLOS ONE, 2014, 9 (07):
  • [7] Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients
    Fabbiani, Massimiliano
    Muscatello, Antonio
    Perseghin, Paolo
    Bani, Marco
    Incontri, Arianna
    Squillace, Nicola
    Lapadula, Giuseppe
    Gori, Andrea
    Bandera, Alessandra
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (02) : 219 - 224
  • [8] Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
    Ciccarelli, N.
    Fabbiani, M.
    Di Giambenedetto, S.
    Fanti, I.
    Baldonero, E.
    Bracciale, L.
    Tamburrini, E.
    Cauda, R.
    De Luca, A.
    Silveri, M. C.
    NEUROLOGY, 2011, 76 (16) : 1403 - 1409
  • [9] Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons
    Okafor, Chukwuemeka N.
    Kelso, Natalie E.
    Bryant, Vaughn
    Burrell, Larry E.
    Miguez, Maria Jose
    Gongvatana, Assawin
    Tashima, Karen T.
    de la Monte, Suzanne
    Cook, Robert L.
    Cohen, Ronald A.
    PSYCHOLOGY HEALTH & MEDICINE, 2017, 22 (03) : 289 - 302
  • [10] A Brief and Feasible Paper-Based Method to Screen for Neurocognitive Impairment in HIV-Infected Patients: The NEU Screen
    Munoz-Moreno, Jose A.
    Prats, Anna
    Perez-Alvarez, Nuria
    Fumaz, Carmina R.
    Garolera, Maite
    Doval, Eduardo
    Negredo, Eugenia
    Ferrer, Maria J.
    Clotet, Bonaventura
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (05) : 585 - 592